The application of strong matrix management and PDCA cycle in the management of severe COVID-19 patients
Open Access
- 17 April 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Critical Care
- Vol. 24 (1), 1-4
- https://doi.org/10.1186/s13054-020-02871-0
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Importation and Human-to-Human Transmission of a Novel Coronavirus in VietnamNew England Journal of Medicine, 2020
- Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitroCell Research, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, ChinaJournal of Medical Virology, 2020
- Variation in critical care services across North America and Western Europe*Critical Care Medicine, 2008
- Effect of Reducing Interns' Work Hours on Serious Medical Errors in Intensive Care UnitsNew England Journal of Medicine, 2004